Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Actinogen Medical ( (AU:ACW) ) has issued an update.
Actinogen Medical Limited, an Australian biotechnology company listed on the ASX under ticker ACW, has issued additional fully paid ordinary shares as part of its ongoing capital management and corporate development activities.
The company has applied for quotation of 2,442,647 new ordinary fully paid shares on the ASX, dated 13 May 2026, following the exercise or conversion of existing options or other convertible securities, modestly increasing its quoted share capital and potentially broadening its shareholder base.
The most recent analyst rating on (AU:ACW) stock is a Buy with a A$0.08 price target. To see the full list of analyst forecasts on Actinogen Medical stock, see the AU:ACW Stock Forecast page.
More about Actinogen Medical
Actinogen Medical Limited is an Australian biotechnology company listed on the ASX under the code ACW. The company operates in the medical and life sciences sector, focusing on the development of therapeutic products, though this filing does not detail its specific pipeline or target indications.
Average Trading Volume: 2,837,323
Technical Sentiment Signal: Buy
Current Market Cap: A$168.7M
Find detailed analytics on ACW stock on TipRanks’ Stock Analysis page.